Tuesday 7 January 2025 ,
Tuesday 7 January 2025 ,
Latest News
23 July, 2015 00:00 00 AM
Print

Arthritis drug may help eczema patients: Study

Researchers behind a new study that showed how an arthritis drug led to a dramatic improvement in eczema patients say it could transform the standard care for the skin condition, for which there is no targeted therapy. (atopic dermatitis) is a chronic skin condition that can adversely affect sleep and quality of life. It causes severe itching and leaves the affected areas of skin red and thickened.
Eczema commonly starts during infancy and persists through into childhood. Some people outgrow it, while others continue to have it into adulthood. Standard treatments, such as steroid creams and oral medicines, often fail to relieve symptoms in patients with moderate to severe eczema.
In the Journal of the American Academy of Dermatology, the researchers - from Yale School of Medicine in New Haven, CT - describe how they successfully used a rheumatoid arthritis drug to treat six patients with moderate to severe eczema.
During treatment, all six patients - whose eczema had not responded to conventional treatments - reported significant reduction in itch. Their skin also reduced in redness and thickening, and they also reported improved sleep. Senior author Brett King, assistant professor of dermatology, says:"These individuals were not only very happy with the results, they also expressed a tremendous sense of relief at being comfortable in their skin for the first time in many years."
Recent years have seen a shift in the debate about the causes of eczema - with more evidence suggesting it may be an autoimmune disease. If that is the case, then Prof. King and colleagues wondered if tofacitinib citrate - a drug approved for the treatment of rheumatoid arthritis - would interrupt the immune response that causes eczema.
    MNT

Comments

More Op-ed stories
In the wake of Burdwan blast, the Indian Home Minister Rajnath Singh recently ordered an immediate neutralisation of the Jamaat-ul-Mujahideen Bangladesh (JMB) terror modules in India. What is the JMB?…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting